Zanvastro (zilganersen sodium)

Intrathecal Vial (Ml)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Generic name: zilganersen sodium
Therapeutic class: Locomotor System

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Zanvastro

Intelligence content is not available yet.

Indications

The following indications are listed for Zanvastro:

  • Alexander Disease

Also known as: Alexander Leukodystrophy, Gfap-Related Alexander Disease.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

CodeTypeDescription
Alexander disease
G31.86ICD10CMAlexander disease

ICD code information from First Databank (FDB).

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data